These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 16114265)

  • 41. Phenotype genotype analysis in 15 patients presenting a congenital myasthenic syndrome due to mutations in DOK7.
    Ben Ammar A; Petit F; Alexandri N; Gaudon K; Bauché S; Rouche A; Gras D; Fournier E; Koenig J; Stojkovic T; Lacour A; Petiot P; Zagnoli F; Viollet L; Pellegrini N; Orlikowski D; Lazaro L; Ferrer X; Stoltenburg G; Paturneau-Jouas M; Hentati F; Fardeau M; Sternberg D; Hantaï D; Richard P; Eymard B
    J Neurol; 2010 May; 257(5):754-66. PubMed ID: 20012313
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 14-3-3 gamma associates with muscle specific kinase and regulates synaptic gene transcription at vertebrate neuromuscular synapse.
    Strochlic L; Cartaud A; Mejat A; Grailhe R; Schaeffer L; Changeux JP; Cartaud J
    Proc Natl Acad Sci U S A; 2004 Dec; 101(52):18189-94. PubMed ID: 15604144
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CHRND mutation causes a congenital myasthenic syndrome by impairing co-clustering of the acetylcholine receptor with rapsyn.
    Müller JS; Baumeister SK; Schara U; Cossins J; Krause S; von der Hagen M; Huebner A; Webster R; Beeson D; Lochmüller H; Abicht A
    Brain; 2006 Oct; 129(Pt 10):2784-93. PubMed ID: 16916845
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Beta-2 Adrenergic Receptor Agonists Enhance AChR Clustering in C2C12 Myotubes: Implications for Therapy of Myasthenic Disorders.
    Clausen L; Cossins J; Beeson D
    J Neuromuscul Dis; 2018; 5(2):231-240. PubMed ID: 29865088
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MuSk function during health and disease.
    Herbst R
    Neurosci Lett; 2020 Jan; 716():134676. PubMed ID: 31811897
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Distinct domains of MuSK mediate its abilities to induce and to associate with postsynaptic specializations.
    Zhou H; Glass DJ; Yancopoulos GD; Sanes JR
    J Cell Biol; 1999 Sep; 146(5):1133-46. PubMed ID: 10477765
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The severity of MUSK pathogenic variants is predicted by the protein domain they disrupt.
    Cocanougher BT; Liu SW; Francescatto L; Behura A; Anneling M; Jackson DG; Deak KL; Hornik CD; ElMallah MK; Pizoli CE; Smith EC; Tan KGQ; McDonald MT
    HGG Adv; 2024 Jul; 5(3):100288. PubMed ID: 38566418
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The receptor tyrosine kinase MuSK is required for neuromuscular junction formation in vivo.
    DeChiara TM; Bowen DC; Valenzuela DM; Simmons MV; Poueymirou WT; Thomas S; Kinetz E; Compton DL; Rojas E; Park JS; Smith C; DiStefano PS; Glass DJ; Burden SJ; Yancopoulos GD
    Cell; 1996 May; 85(4):501-12. PubMed ID: 8653786
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diverse molecular mechanisms involved in AChR deficiency due to rapsyn mutations.
    Cossins J; Burke G; Maxwell S; Spearman H; Man S; Kuks J; Vincent A; Palace J; Fuhrer C; Beeson D
    Brain; 2006 Oct; 129(Pt 10):2773-83. PubMed ID: 16945936
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synaptic dysfunction in congenital myasthenic syndromes.
    Beeson D
    Ann N Y Acad Sci; 2012 Dec; 1275():63-9. PubMed ID: 23278579
    [TBL] [Abstract][Full Text] [Related]  

  • 51. ARGX-119 is an agonist antibody for human MuSK that reverses disease relapse in a mouse model of congenital myasthenic syndrome.
    Vanhauwaert R; Oury J; Vankerckhoven B; Steyaert C; Jensen SM; Vergoossen DLE; Kneip C; Santana L; Lim JL; Plomp JJ; Augustinus R; Koide S; Blanchetot C; Ulrichts P; Huijbers MG; Silence K; Burden SJ
    Sci Transl Med; 2024 Sep; 16(765):eado7189. PubMed ID: 39292800
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Congenital myasthenic syndromes: genetic defects of the neuromuscular junction.
    Ohno K; Engel AG
    Curr Neurol Neurosci Rep; 2002 Jan; 2(1):78-88. PubMed ID: 11898587
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Implication of geranylgeranyltransferase I in synapse formation.
    Luo ZG; Je HS; Wang Q; Yang F; Dobbins GC; Yang ZH; Xiong WC; Lu B; Mei L
    Neuron; 2003 Nov; 40(4):703-17. PubMed ID: 14622576
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Severe congenital myasthenic syndrome due to homozygosity of the 1293insG epsilon-acetylcholine receptor subunit mutation.
    Sieb JP; Kraner S; Schrank B; Reitter B; Goebel TH; Tzartos SJ; Steinlein OK
    Ann Neurol; 2000 Sep; 48(3):379-83. PubMed ID: 10976646
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synapse disassembly and formation of new synapses in postnatal muscle upon conditional inactivation of MuSK.
    Hesser BA; Henschel O; Witzemann V
    Mol Cell Neurosci; 2006 Mar; 31(3):470-80. PubMed ID: 16337809
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Passive and active immunization models of MuSK-Ab positive myasthenia: electrophysiological evidence for pre and postsynaptic defects.
    Viegas S; Jacobson L; Waters P; Cossins J; Jacob S; Leite MI; Webster R; Vincent A
    Exp Neurol; 2012 Apr; 234(2):506-12. PubMed ID: 22326541
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Restoration of synapse formation in Musk mutant mice expressing a Musk/Trk chimeric receptor.
    Herbst R; Avetisova E; Burden SJ
    Development; 2002 Dec; 129(23):5449-60. PubMed ID: 12403715
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Congenital myasthenic syndromes: recent advances.
    Beeson D
    Curr Opin Neurol; 2016 Oct; 29(5):565-71. PubMed ID: 27472506
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Congenital myasthenic syndromes].
    Ohno K
    Rinsho Shinkeigaku; 2012; 52(11):1159-61. PubMed ID: 23196549
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Electrophysiological and morphological characterization of a case of autosomal recessive congenital myasthenic syndrome with acetylcholine receptor deficiency due to a N88K rapsyn homozygous mutation.
    Yasaki E; Prioleau C; Barbier J; Richard P; Andreux F; Leroy JP; Dartevelle P; Koenig J; Molgó J; Fardeau M; Eymard B; Hantaï D
    Neuromuscul Disord; 2004 Jan; 14(1):24-32. PubMed ID: 14659409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.